Welcome to plenary session.

I'm Dr. Vinay Prasad. I'm an associate professor at the University of California, San Francisco.

My interests are medicine, hematology, oncology, and health policy, and that's what you're going to get on this podcast.

This week, we got a great episode in store for you.

We've got an interview, and I think you're going to really like this.

But first, a plug.

If you like this podcast, check out the new website, www.

www. plenary session podcast.com.

We've got show notes, we've got trial summaries, we've got everything you could want on the website.

Follow us on Twitter at plenary underscore session.

Write a review for us on the iTunes store.

And become a supporter for this podcast on Patreon.

Patreon backers get access to the slides for presentations I give on plenary session.

You also get a few bonus lectures.

And with that, let's start the show.

All right, we're rolling.

I'm back in plenary session, video edition, joined by Daniel Myers.

Daniel Myers is a resident in Calgary at the University of Calgary. And he is going into internal

medicine, hopefully oncology. And he is the author of a new paper. That's part of the booth legacy.

It's called industry payments to U.S. physicians for cancer therapeutics and analysis of 2016 to 2018 open payments Legacy. It's called Industry Payments to U.S. Physicians for Cancer Therapeutics

and analysis of 2016 to 2018 open payments data. It's in the Journal of Cancer Policy. We will link to it in the show notes. So Daniel, it's a pleasure to speak with you.

Thanks very much for having me that I am a big fan of the show. So I'm excited to be here today to chat about the paper and hopefully whatever other interesting topics come up.

...